Anna Kreutzman

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Chronic Myeloid Leukemia

Top Venues

Cancer immunology, immunotherapy : CII

Cancer research communications

ImmunoViroTherapy lab

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

ImmunoViroTherapy lab Nov 01 2019

Finland

Senior Postdoctoral Researcher :: Drug Research Program Helsinki (DRP), Faculty of Pharmacy

Hematology Research Unit Helsinki - Oct 31 2019

Finland

Postdoctoral Researcher :: University of Helsinki

Education History

University of Helsinki

Finland

PHD :: Faculty of Medicine

Publications

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas K Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Mohamed El Missiry
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer research communications 3 (7) (2023)
Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas K Mirtti, Mohamed El Missiry, Anna Kreutzman
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 11 (1) (2022)
Henna Kasanen, Micaela M Hernberg, Siru Mäkelä, Oscar Brück, Susanna Juteau, Laura Kohtamäki, Mette Ilander, Mohamed El Missiry, Anna Kreutzman
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer immunology, immunotherapy : CII 69 (5) (2020)
Anna Kreutzman, Bhagwan Yadav, Tim H Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen, Mohamed El Missiry
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. Oncoimmunology 8 (9) (2019)